Medical tourism discovery platform CureMeAbroad has raised $600,000 in a pre-seed funding round, with backing from investors Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, and Vikrant Potnis, the company announced in April 2026.
Founded in June 2025 by Aditya Oza and Mikhail Bohra, CureMeAbroad is an AI-first platform that connects international patients with hospitals, surgeons, and treatment destinations. The platform maintains a directory of over 6,000 hospitals across 47 countries and 45 specialties, and works with more than 380 accredited partner hospitals in key medical tourism hubs including Mexico, Turkey, Thailand, India, and Georgia.
The company said the fresh capital will be directed toward technology investments, including expanding its AI cost estimator — trained on over 634 procedure records — as well as its clinical matching models and multilingual patient intelligence layer. The platform operates under HIPAA certification.
CureMeAbroad plans to accelerate growth in the GCC, UK, and Africa markets. The company says it aims to address persistent industry challenges including opaque pricing, unverified clinic listings, reliance on WhatsApp-based agents, lack of trust, and limited aftercare accountability.
The platform competes with services such as Bookimed, PlacidWay, The Medical Tourism Company, and Medical Departures.
The funding comes as the global medical tourism market is projected to reach $174 billion by 2035, according to a market report cited by the company, suggesting the sector could offer significant room for platforms seeking to formalize and digitize patient discovery and care coordination across borders.
Source: Entrackr : Latest Posts